Publication | Open Access

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study

Hematological MalignancyPrognostic EvaluationPediatric HematologyMedicineClinical UtilityPrognosisHematologyPediatricsClinical EpidemiologyOutcomes ResearchProspective StudyPublic HealthOncologyEpidemiologyRisk-based Therapy